November 14, 2019

Commercial website launched for évolis™

November 14, 2019

Final Share Issue to La Jolla Cove – Appendix 3B

November 14, 2019

Cellmid Completes $1.5M Placement

November 14, 2019

Appendix 4C

November 14, 2019

Notice of Extraordinary General Meeting / Proxy Form

November 14, 2019

Treg Antibody Patent Allowed in USA

November 14, 2019

Appendix 3B

November 14, 2019

Ceasing to be a substantial holder

November 13, 2019

Change in substantial holding

Shop évolis®